Valuation : Boston Scientific Corporation

Market Cap 67.88B 58.49B 54.84B 50.06B 94.31B 6,488B 94.61B 651B 254B 3,275B 255B 249B 10,859B P/E 2026 *
17.5x
P/E 2027 * 18.5x
Enterprise Value 76.6B 66.01B 61.89B 56.49B 106B 7,321B 107B 734B 286B 3,696B 288B 281B 12,254B EV / Sales 2026 *
3.59x
EV / Sales 2027 * 3.28x
Free-Float
82.47%
Yield 2026 *
-
Yield 2027 * -
1 day+0.13%
1 week-7.01%
Current month+0.24%
1 month+1.69%
3 months-4.62%
6 months-39.05%
Current year-50.88%
1 week 46.5
Extreme 46.5
50.38
1 month 44.43
Extreme 44.43
52.99
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 31/10/2011
Director of Finance/CFO 52 29/06/2025
Chief Tech/Sci/R&D Officer - 31/08/2009
Director TitleAgeSince
Chairman 61 02/05/2016
Director/Board Member 74 28/02/2014
Director/Board Member 74 14/04/2016
Date Insider Type Main position Quantity % Market Cap.
25/08/26 Buy

Director

2,040 0.0001%
11/08/26 Other

Controller/Auditor

2,930 0.0002%
10/08/26 Other

Chief Financial Officer

9,908 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
+0.36%-7.01%-55.71%-12.92% 67.88B
-1.35%-1.13%+27.04%+14.12% 230B
+0.18%-1.27%+5.25%-17.37% 152B
+1.51%-1.64%-21.37%+23.59% 132B
+0.29%+0.47%+11.06%+18.65% 52B
+0.66%-1.69%-16.57%-13.62% 51.05B
-2.44%-3.25%+23.11%+28.29% 43.38B
-1.56%+0.97%+39.32%+47.34% 40.74B
-5.31%-1.74%+117.39%+36.28% 32.55B
+1.94%+3.81%-12.73%+48.46% 34.67B
Average -0.59%-0.93%+11.68%+17.28% 83.58B
Weighted average by Cap. -0.36%-1.31%+7.34%+10.92%

Financials

2026 *2027 *
Net sales 21.37B 18.41B 17.26B 15.76B 29.68B 2,042B 29.78B 205B 79.91B 1,031B 80.22B 78.47B 3,418B 22.33B 19.24B 18.04B 16.47B 31.02B 2,134B 31.12B 214B 83.51B 1,077B 83.84B 82.01B 3,572B
Net income 3.84B 3.31B 3.1B 2.83B 5.33B 367B 5.35B 36.8B 14.36B 185B 14.41B 14.1B 614B 3.69B 3.18B 2.98B 2.72B 5.12B 352B 5.14B 35.33B 13.79B 178B 13.84B 13.54B 590B
Net Debt 8.72B 7.51B 7.04B 6.43B 12.11B 833B 12.15B 83.56B 32.6B 421B 32.73B 32.02B 1,394B 5.45B 4.7B 4.4B 4.02B 7.57B 521B 7.6B 52.26B 20.39B 263B 20.47B 20.02B 872B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
28/08/26 US$46.84 +0.36% 17,146,221
27/08/26 US$46.67 -3.11% 16,277,169
26/08/26 US$48.17 -3.39% 36,584,800
25/08/26 US$49.86 +1.73% 17,368,920
24/08/26 US$49.01 -2.70% 22,027,880
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
46.84USD
Average target price
62.69USD
Spread / Average Target
+33.84%

Quarterly revenue - Rate of surprise